Tag Archives: College of American Pathologists


Sonora Quest launches direct access testing

Sonora Quest Laboratories has launched My Lab ReQuest™, a new service empowering consumers in Arizona to take control of their health by ordering certain lab tests on their own. A new Arizona law, effective July 3, now allows consumers Direct Access Testing from a licensed clinical laboratory without physician orders.

Direct Access Testing is the latest service from Sonora Quest Laboratories, the market leader, which is trusted by more doctors, hospitals and other healthcare providers throughout Arizona. Sonora Quest is part of the nation’s largest integrated laboratory system, providing laboratory services to patients in settings from primary care and specialists to hospital and long-term care, and performing more than 57 million diagnostic tests annually.

All patients across the state of Arizona will benefit from the Sonora Quest Direct Access Testing service, which is offered at all of its 70 Patient Service Centers statewide. This includes access to centers in the metropolitan areas as well as communities at all ends of the State. With locations from Kingman to Show Low and Sierra Vista to Yuma, Sonora Quest is able to reach the largest portion of Arizona residents and visitors and is the only laboratory offering Direct Access Testing to the majority of Arizona’s rural communities.

“Naturally we are pleased to help consumers play a more active role in managing their health,” said Sonora Quest Medical Director, Robert Stern, M.D. “Direct Access Testing gives consumers more choice, flexibility and control over their own health in a convenient, efficient and confidential way. This empowerment gets even better for consumers when these tests and potential follow-up actions occur as part of a strong relationship between a consumer and his or her primary health care provider.”

All Direct Access Tests offered by Sonora Quest are approved by the U.S. Food and Drug Administration. In addition, Sonora Quest’s laboratories are accredited by the College of American Pathologists, the laboratory industry’s gold-standard accrediting agency, a defining distinction of Sonora Quest’s outstanding quality and proven testing processes. To ensure consistent quality and accuracy of testing, Sonora Quest Laboratories voluntarily participates in the College of American Pathologists’ proficiency testing as well as in-depth inspections of all laboratories.

“This is a new era in health care consumerism, and as Arizona’s leading provider of diagnostic testing and information we will do all we can to support the needs of the entire healthcare community,” said David A. Dexter, president and CEO of Sonora Quest Laboratories. “Consumers expect the most accurate and up-to-date diagnostic information to proactively manage their health so that they can make educated decisions,” Dexter said.

With My Lab ReQuest, Sonora Quest Laboratories offers consumers a select menu of wellness health profiles and tests, including screening for environmental/pollen allergies, diabetes, heart health, immunity and infectious diseases. All tests are available via an easy online ordering form or at any of their convenient locations and are fully transparent with price clearly indicated for each test. Once completed, consumers have the choice of retrieving their results online through Sonora Quest’s Patient Portal, or having them sent by email or postal mail.


Phoenix Pathologist Earns Distinguished Patient Award

The College of American Pathologists (CAP) awarded Robert J. Penny, MD, PhD, FCAP, from Phoenix, the CAP Distinguished Patient Care Award at a special ceremony held in San Diego on September 8, 2012, at CAP ’12 — THE Pathologists’ Meeting.

Dr. Penny was recognized for his extensive scientific translational research to accelerate the adoption of molecular pathways and associated therapies into the field of pathology and oncology to improve the lives of cancer patients.

“I am deeply honored to be recognized by my peers with the CAP Distinguished Patient Care Award,” said Dr. Penny. “As pathologists, we are the current and future innovators to drive molecular pathways and their associated therapies into clinical medicine. My work recognized here is a very small start to a remarkable future for the patients of tomorrow.”

Dr. Penny is the co-founder and chief executive officer of the International Genomics Consortium (IGC) in Phoenix. While at IGC, he began the national Expression Project for Oncology (expO), which provides a free public gene expression database of 2,000 cancers with clinical outcomes for translation. The National Institutes of Health cited expO’s success as critical in deciding to launch The Cancer Genome Atlas (TCGA), a national project to improve the prevention, diagnosis, and treatment of cancer.

Also while at IGC, he founded the Molecular Profiling Institute and served as its first chief executive officer and chairman of the board. Dr. Penny’s vision was to bring to surgical pathology a holistic, evidenced-based, integrated molecular pathway analysis with accompanying therapies provided by pathologists for oncologists. He developed the Molecular Profiling Institute’s portfolio of molecular testing and pharmaceutical services, which includes his successful commercially available holistic genomic analysis of cancer with its award-winning surgical oncology report (Target Now) that matches molecular mechanisms with associated oncology therapies. The test has been paradigm changing. Patients who failed rounds of chemotherapy frequently benefited from the targeted therapy. Today, tens of thousands of patients annually use the test throughout the United States.

Dr. Penny is a recognized expert in the translation of diagnostics into patient care as well as in creating high-quality biorepositories. He has established two national esoteric reference medical laboratories, a national tissue bank and analysis center, and a national genomics program to help accelerate the translation of new diagnostics. He has helped bring cellular and molecular diagnostic, prognostic, and therapeutic testing to patient care throughout the nation with leukemia, lymphoma, and solid tumors.
Dr. Penny received his BS, MS, PhD (genetics), and MD from the University of Arizona and then went on to receive his pathology training at Harvard’s Brigham & Women’s Hospital in Boston, where he served as chief resident and completed fellowships in hematopathology and surgical pathology. Dr. Penny’s contributions include a textbook in oncology, publication of articles, and leadership roles in laboratory management.
The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society serving more than 18,000 physician members and the global laboratory community. It is the world’s largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care.